SCHEMBL2404007

SCHEMBL2404007

NC(=O)c1ccc(-c2cccc(N3CCC(CN(Cc4cscn4)C(=O)O)CC3)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CPT2 P23786 1/20 0.35
CPT1A P50416 1/20 0.35
HTR6 P50406 1/20 0.35
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
KDM1A O60341 1/20 0.35
PRKD1 Q15139 1/20 0.34
PRKD2 Q9BZL6 1/20 0.34
HTR1A P08908 1/20 0.33
HTR2A P28223 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
DGAT1 O75907 1/20 0.33
GAA P10253 1/20 0.33
TGFBR1 P36897 3/20 0.33
KDR P35968 2/20 0.33
MAPK14 Q16539 1/20 0.33
CKS1B P61024 1/20 0.33
SKP1 P63208 1/20 0.33
SKP2 Q13309 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2408111 0.92 PRKD1 (0.37) PRKD1PRKD2HTR1AHTR2AFFAR4
SCHEMBL2407695 0.92 CPT2 (0.34) CPT2CPT1AHTR6ITGB3ITGA2B
SCHEMBL2405627 0.90 CNR1 (0.38) CPT1AFFAR4DGAT1
SCHEMBL2406148 0.87 HSD11B1 (0.38) FFAR4CKS1BSKP1SKP2AGTR2
SCHEMBL2411477 0.87 CNR1 (0.40) GAAPKM
SCHEMBL2408758 0.87 FFAR4 (0.36) FFAR4DGAT1CKS1BSKP1SKP2
SCHEMBL2406060 0.86 DKK1 (0.42) FFAR4DGAT1AGTR2
SCHEMBL2411198 0.86 PIM1 (0.36) HTR1AHTR2AFFAR4CKS1BSKP1
SCHEMBL2405641 0.86 FFAR4 (0.32) HTR1AHTR2AFFAR4CKS1BSKP1
SCHEMBL2405902 0.85 FFAR4 (0.41) FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8912218-B2 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof SANOFI (FR) 2014-12-16 US disclosed
US-20110212963-A1 ALKYLTHIAZOL CARBAMATE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212963-A1 ALKYLTHIAZOL CARBAMATE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF MET, ALK, REL CPT2 1198/4885CPT1A 498/4885HTR6 1031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.